U.S. Patent and Trademark Office Publishes Ruprecht-Karls-Universitat Heidelberg and Deutsches Krebsforschungszentrum's Patent Application for Combination Therapy with a Flavagline and 2-Deoxyglucose

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Global IP News (India), June 24, 2018 Pharmaceutical Patent News, 2pp
  • Additional Information
    • Abstract:
      Alexandria, June 24 -- U.S. Patent and Trademark Office has published Ruprecht-Karls-Universitat Heidelberg and Deutsches Krebsforschungszentrum's patent application for combination therapy with a flavagline and 2-deoxyglucose. Von Knebel Doeberitz Magnus, Kloor Matthias, Ahadova Aysel, Kopitz Juergen, Krammer Peter and Li-Weber Min developed the invention. The patent application number is 15/738378. International Patent Classification codes are A61K 31/7004 20060101 A61K031/7004, A61K 31/343 20060101 A61K031/343, A61K 31/36 20060101 A61K031/36, A61K 45/06 20060101 A61K045/06 and A61P 35/00 20060101 A61P035/00...